NAC639.682. Record for each patient.

     1. A pharmacy engaged in the practice of compounding and dispensing parenteral solutions shall have on the premises or readily accessible:

     (a) A record for each patient being treated with parenteral therapy;

     (b) A summary of the most recent hospitalization of the patient or the patient’s medical history; and

     (c) Any notes taken by the pharmacist concerning the progress of the patient which document any contact with the patient or the practitioner concerning the parenteral therapy.

     2. In addition to any other requirements for keeping records, the following records must be maintained in the pharmacy:

     (a) Records concerning any prescriptions and medical supplies furnished to the patient.

     (b) Information relevant to the patient’s parenteral therapy, including, but not limited to:

          (1) The patient’s name, age, height, weight, sex and address and the telephone number of the location where the patient is receiving parenteral therapy;

          (2) The diagnosis of the patient; and

          (3) The patient’s history of medication, including his or her current regimen concerning diet and medication and any allergies to drugs or food.

     (c) Data of a laboratory relevant to the parenteral therapy.

     (d) If the patient is using a parenteral solution in the patient’s home, in a facility for the dependent or in a medical facility which does not furnish the parenteral solution from a pharmacy located in that medical facility, records indicating that the care of the patient is coordinated by the pharmacy, practitioner and nursing personnel before the administration of the parenteral solution, including:

          (1) Documentation of all orders for medication, laboratory tests or other treatment related to the medication of the patient.

          (2) Documentation of all orders given by a practitioner which were communicated to nursing personnel by a pharmacist.

          (3) Documentation that a total assessment of the patient has been performed.

          (4) Documentation that a plan for the parenteral therapy of the patient has been developed by the pharmacy. The plan must include:

               (I) The identification of any problem related to a drug that is administered to the patient; and

               (II) Any suggested solution for that problem and the monitoring of the results of the therapy.

     3. As used in this section, “total assessment” means an evaluation of the circumstances of the administration of parenteral therapy to a patient in the patient’s home, in a facility for the dependent or in a medical facility which does not furnish the parenteral solution from a pharmacy located within that medical facility that includes a review of:

     (a) The state of the disease of the patient;

     (b) The regimen of medication of the patient;

     (c) The medical history of the patient;

     (d) Any therapies other than parenteral therapy administered to the patient; and

     (e) If the patient is using the parenteral solution in the patient’s home, the ability of the patient to receive parenteral therapy in his or her home.

     (Added to NAC by Bd. of Pharmacy, eff. 8-14-87; A 7-7-94)